Bea Kuiperij

Assistant professor

Radboud University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

ORCID

Google Scholar

Articles (11)

No replicating evidence for anti‐amyloid‐β autoantibodies in cerebral amyloid angiopathy‐related inflammation

Article Link

Year:

2024

Reply to "Decreased Cerebrospinal Fluid Amyloid Beta 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy"

Article Link

Year:

2023

Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy

Article Link

Year:

2023

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach

Article Link

Year:

2021

White Matter Hyperintensities Are No Major Confounder for Alzheimer’s Disease Cerebrospinal Fluid Biomarkers

Article Link

Year:

2021

Disturbed balance in the expression of MMP9 and TIMP3 in cerebral amyloid angiopathy-related intracerebral haemorrhage

Article Link

Year:

2020

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease

Article Link

Year:

2020

Proteomic profiling of striatal tissue of a rat model of Parkinson's disease after implantation of collagen‐encapsulated human umbilical cord mesenchymal stem cells

Article Link

Year:

2020

Cerebrospinal fluid myelin basic protein is elevated in multiple system atrophy

Article Link

Year:

2020

CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD

Article Link

Year:

2020

Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms.

Article Link

Year:

2020

Collaborators (3)

Jolein Gloerich

Assistant Professor

Radboudumc

NETHERLANDS

Marcel M. Verbeek

NETHERLANDS

Marco Duering

LMU University Hospital

UNITED STATES

Bea Kuiperij

Research Interests

Explore related searches

Contact this professor

Articles (11)

No replicating evidence for anti‐amyloid‐β autoantibodies in cerebral amyloid angiopathy‐related inflammation

Reply to "Decreased Cerebrospinal Fluid Amyloid Beta 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy"

Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach

White Matter Hyperintensities Are No Major Confounder for Alzheimer’s Disease Cerebrospinal Fluid Biomarkers

Disturbed balance in the expression of MMP9 and TIMP3 in cerebral amyloid angiopathy-related intracerebral haemorrhage

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease

Proteomic profiling of striatal tissue of a rat model of Parkinson's disease after implantation of collagen‐encapsulated human umbilical cord mesenchymal stem cells

Cerebrospinal fluid myelin basic protein is elevated in multiple system atrophy

CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD

Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms.

Collaborators (3)

Jolein Gloerich

Marcel M. Verbeek

Marco Duering

How do I reach out?

Meet Kite AI